Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The hereditary amyloidoses.

Merrill D Benson1

  • 1Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, 635 Barnhill Drive, MS-128, Indianapolis, IN 46202-5126, USA. mdbenson@iupui.edu

Best Practice & Research. Clinical Rheumatology
|May 5, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Detection of Circulating Transthyretin Amyloid Aggregates in Plasma: A Novel Biomarker for Transthyretin Amyloidosis.

Circulation·2024
Same author

Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update.

Journal of neurology·2022
Same author

Guidelines and new directions in the therapy and monitoring of ATTRv amyloidosis.

Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis·2022
Same author

Post-translational modification of amyloid a protein in patients with AA amyloidosis.

Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis·2021
Same author

Tissue biopsy for the diagnosis of amyloidosis: experience from some centres.

Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis·2021
Same author

Design and Rationale of the Global Phase 3 NEURO-TTRansform Study of Antisense Oligonucleotide AKCEA-TTR-L<sub>Rx</sub> (ION-682884-CS3) in Hereditary Transthyretin-Mediated Amyloid Polyneuropathy.

Neurology and therapy·2021
Same journal

The young adult with Juvenile Idiopathic Arthritis (JIA): A clinical review of transition, complications, and psychosocial management.

Best practice & research. Clinical rheumatology·2026
Same journal

Impact of fatigue on rheumatic diseases: Current perspectives.

Best practice & research. Clinical rheumatology·2026
Same journal

Pneumocystis prophylaxis in rheumatic disease.

Best practice & research. Clinical rheumatology·2026
Same journal

Cutaneous manifestations in myositis syndromes.

Best practice & research. Clinical rheumatology·2026
Same journal

Systemic sclerosis: A comprehensive systematic review of global epidemiology, sex and ethnic disparities, disease burden, and organ-specific involvement.

Best practice & research. Clinical rheumatology·2026
Same journal

Alopecia across the spectrum of rheumatic disease.

Best practice & research. Clinical rheumatology·2026
See all related articles

Hereditary amyloidosis, a genetic disease causing protein deposits in organs, mimics common amyloidosis types. Accurate diagnosis is crucial for effective treatment and genetic counseling.

Area of Science:

  • Genetics
  • Internal Medicine
  • Pathology

Background:

  • Hereditary amyloidosis is a systemic disease characterized by beta-structured protein deposits affecting multiple organ systems.
  • It often presents similarly to more common forms of systemic amyloidosis, such as immunoglobulin light chain (AL) and reactive (AA) amyloidosis.
  • Distinguishing hereditary amyloidosis from other types is diagnostically challenging but essential.

Purpose of the Study:

  • To present hereditary amyloidosis as a distinct disease entity.
  • To outline diagnostic approaches for identifying specific types of hereditary amyloidosis.
  • To discuss current and potential future therapies and the role of research.

Main Methods:

  • This section is not detailed in the provided abstract.

Related Experiment Videos

  • The abstract implies a review or synthesis of existing knowledge.
  • Focus is on understanding the disease, diagnosis, and treatment.

    • Main Results:

    • The abstract does not present specific results but outlines the scope of the chapter.
    • It emphasizes the diagnostic challenge in differentiating hereditary amyloidosis.
    • Precise diagnosis is highlighted as critical for management.

    Conclusions:

    • Hereditary amyloidosis requires recognition as a distinct genetic condition.
    • Accurate diagnosis is paramount for appropriate therapy and genetic counseling.
    • Understanding the disease necessitates integrated basic and clinical research efforts.